28.09.2017 • TopicsTemple UniversitySGSSenn Chemicals

M&A in Pharma and CRO/CMO Industry

(c) cacaroot/Fotolia
(c) cacaroot/Fotolia

Challenges caused by a merger or an acquisition can be manifold, no matter whether it is your own organization that is going through M&A and the integration phase or any of your outsourcing partners or customers. Distractions or disruptions are pre-programmed and sometimes inevitable, thus, it gets hard to maintain business as usual. In such a phase it is important not to lose focus on customer relationship and ongoing projects. CHEManager International asked executives and opinion leaders in the chemical and pharmaceutical market to share their experience and advice. For instance, we wanted to know:

  • Will the consolidation in the pharmaceutical industry level off or will it even intensify?
  • Does the consolidation in the pharma industry create a necessity for CROs/CMOs to consolidate?
  • How big of an issue is a merger or an acquisition for ongoing projects?
  • How can outsourcing partners maintain their focus and guarantee confidentiality in their projects?

Read the insightful answers of the experts here

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.